Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

The addition of hysterectomy to RRSO in a 40 year old BRCA1 mutation carrier results in a mean gain of 4.9 additional months of life and is cost-effective.